PBM & Pharma Price Transparency Avoidance
- Drug manufacturers and pharmacy benefit managers received a important reprieve from President Trump on Friday: they will not be required to publicly post the actual prices of prescription...
- Net drug prices - the amounts health insurance companies and PBMs pay to drugmakers after rebates - are highly valuable data that underpin the entire economic foundation of...
- The affordable Care Act and other federal laws mandated widespread transparency of prices across the healthcare industry, which has historically shielded its high prices.
“`html
Trump Administration Delays Public Disclosure of Prescription Drug Prices
Table of Contents
Background: The push for Price Transparency
Drug manufacturers and pharmacy benefit managers received a important reprieve from President Trump on Friday: they will not be required to publicly post the actual prices of prescription drugs,despite a federal law mandating this disclosure over five years ago.
Net drug prices – the amounts health insurance companies and PBMs pay to drugmakers after rebates – are highly valuable data that underpin the entire economic foundation of the U.S. pharmaceutical industry. The Trump administration’s decision, outlined in a new proposed rule, effectively means this crucial pricing data will likely remain hidden from public view for the foreseeable future.
The affordable Care Act and other federal laws mandated widespread transparency of prices across the healthcare industry, which has historically shielded its high prices. Hospitals have been required to post their prices sence 2019,though compliance and enforcement have been weak. Health insurers have had to publish their negotiated rates for hospital and doctor services since 2022, but the data released has often been unwieldy and contained large amounts of relatively unhelpful pricing details.
Why Net Drug Prices Matter
Understanding net drug prices is critical for several reasons:
- Cost Control: Transparency allows for better negotiation and perhaps lower drug costs for consumers and insurers.
- market Efficiency: Publicly available data fosters a more competitive market, potentially driving innovation and efficiency.
- Accountability: It holds drug manufacturers and PBMs accountable for pricing practices.
- Understanding Rebates: net prices reveal the true impact of rebates, which often don’t translate into lower costs for patients at the pharmacy counter.
The Role of Pharmacy Benefit Managers (PBMs)
PBMs play a significant role in determining net drug prices. They negotiate rebates with drug manufacturers on behalf of health plans and employers. However, the complexity of these negotiations and the lack of transparency surrounding rebates have been a major source of concern. Critics argue that PBMs may not always pass on the full benefit of rebates to consumers.
How PBMs Operate: A Simplified Overview
| Step | Description |
|---|